Publications
-
Eritja, A; Pérez-Olives, C; Falcón, DAR; Caus, M; García-Carrasco, A; Martinez, A; Escalante, EJ; Martin, M; Van Zonneveld, AJ; Bijkerk, R; Bozic, M
N-methyl-D-aspartate receptor inhibition protects against obesity-induced kidney disease
NEPHROLOGY DIALYSIS TRANSPLANTATION -. .
-
Planella-Cornudella, M; Roca-Saladrigues, N; Lopez-Baez, V; Jatem-Escalante, E; Sole-Mir, E; Gomez-Arbones, X; Madrid-Aris, A; Segarra-Medrano, A
Lymphocytic expression and IL-2 levels in calcineurin inhibitor-resistant nephrotic syndrome due to focal segmental glomerulosclerosis: implications for calcineurin inhibitor response
NEFROLOGIA 46 501402-501402. .
-
Planella Cornudella, M.; Roca-Saladrigues, N.; López-Baez, V.; Jatem-Escalante, E.; Solé-Mir, E.; Gómez-Arbonés, X.; Madrid-Aris, A.; Segarra-Medrano, A.
Lymphocytic expression and IL-2 levels in calcineurin inhibitor-resistant nephrotic syndrome due to focal segmental glomerulosclerosis: Implications for calcineurin inhibitor response; Expresión linfocitaria y niveles de IL-2 en el síndrome nefrótico corticorresistente por glomeruloesclerosis focal y segmentaria: implicaciones en la respuesta a los inhibidores de calcineurina
NEFROLOGIA 46 -. .
-
Rodríguez, JG; Valdivielso, JM; Escalante, EJ; Sans, MB; Carrasco, AG; Salas, JD; Alcalá, AM; Ribas, MP; Roldan, EO; Medrano, AS; Conde, MLM
Development of a multiple urinary biomarker model to predict the tubulointerstitial fibrosis area in patients with primary IgA Nephropathy
BMC Nephrology 26 141-141. .
-
González Rodríguez J.; Jatem Escalante E.; Buil Campo J.C.; Pinyol Ribas M.; Martín Conde M.L.
Late-Onset Lupus Nephritis: Clinical-Epidemiological, Histological, Prognostic, and Therapeutic Implications: A Single-Center Experience from Northeastern Spain
Glomerular Diseases 5 109-118. .
-
González, J; Jatem, E; del Carpio, J; Castañeda, ZI; Abó, AI; Martín, ML; Segarra, A
Epidemiological, clinical and prognostic issues in SARS-CoV-2 infection or vaccination-related glomerular disease: Our single-center experience
NEFROLOGIA 44 582-583. .
-
Gonzalez J; Jatem E; Roig J; Valtierra N; Ostos E; Abo A; Santacana M; Garcia A; Segarra A
Usefulness of urinary biomarkers to estimate the interstitial fibrosis surface in diabetic nephropathy with normal kidney function.
NEPHROLOGY DIALYSIS TRANSPLANTATION 37 2102-2110. .
-
Roca, N; Jatem, E; Abo, A; Santacana, M; Cruz, A; Madrid, A; Fraga, G; Martin, M; Gonzalez, J; Martinez, C; Balius, A; Segarra, A
CD44-negative parietal-epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome.
Clinical Kidney Journal 15 545-552. .
-
Molina, M; Sorolla, C; Samsó, E; Carcaña, M; Martín, ML; Jatem, E; Pitarch, G; Montero, L; Lauzurica, R; Segarra, A
Quality of Life in Long-Term Renal Transplant Patients: A Controversial Subject
TRANSPLANTATION PROCEEDINGS 54 91-93. .
-
Molina, M; Sorolla, C; Samsó, E; Carcaña, M; Martín, ML; Jatem, E; Pitarch, G; Montero, L; Lauzurica, R; Segarra, A
Cost of Traveling to Follow-up Appointments at Kidney Transplant Clinics
TRANSPLANTATION PROCEEDINGS 54 94-95. .
-
Medrano AS; Muijsemberg A; Wimbury D; Martin M; Jatem E; González J; Colás-Campás L; García-Carrasco A; Martínez C; Barratt J
Relationship between IgA1 lectin-binding specificities, mesangial C4d deposits and clinical phenotypes in IgA nephropathy.
NEPHROLOGY DIALYSIS TRANSPLANTATION 37 318-325. .
-
Jatem-Escalante, E; Martín-Conde, ML; Gracia-Lavedan, E; Benítez, ID; Gonzalez, J; Colás, L; Garcia-Carrasco, A; Martínez, C; Segarra-Medrano, A
Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy
Clinical Kidney Journal 14 2556-2562. .
Projects
- miRNAs como Potentes Reguladores de la nefropatía asociada a Obesidad. Identificación de potenciales biomarcadores y Dianas Terapéuticas (MIR-PROTECT)
